Editorial: Engineered immune cells in cancer immunotherapy (EICCI)

Front Immunol. 2022 Dec 20:13:1119363. doi: 10.3389/fimmu.2022.1119363. eCollection 2022.
No abstract available

Keywords: CAR-T cells; TCR-engineered T cells; adoptive cell theraphy; mechanisms of resistance; tumor antigens.

Publication types

  • Editorial

MeSH terms

  • Humans
  • Immunotherapy
  • Neoplasms* / therapy
  • T-Lymphocytes*